Stomach cancer is challenging to detect early due to vague symptoms, often diagnosed at advanced stages. Diagnosis involves ...

The Las Vegas Medical District is set to expand with a new testing facility that officials say will strengthen the region’s ...

Bent bone dysplasia (BBD) is a perinatal-lethal skeletal disorder caused by pathogenic FGFR2 mutations that disrupt bone ...

Multigene next-generation sequencing (NGS) performed directly on tumor tissue can accurately identify pathogenic variants in epithelial ovarian cancer (EOC), detecting both somatic and germline ...

Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented ...

Many babies enter the world with silent metabolic or genetic conditions. Today, standard newborn screening can check for some ...

Circulating tumor DNA (ctDNA) is a promising biomarker for monitoring treatment response and progression-free survival in ...

Although COVID-19 testing decreased during the study period, influenza and respiratory syncytial virus testing increased among hospitalized youth.

Mr. Tahmooressi joins iMDx most recently from Astellas Pharma where he was the Global Brand Lead of Established Products Marketing covering its transplant, urology and oncology brands. He also worked ...

“With newer advances, cancer care has definitely reached a point where it is no longer a threat to life, but a journey that ...

Despite growing awareness of the importance of genetic risk assessment, the adoption of cascade testing remains limited in LATAM. Key barriers include restricted access to genetic services, financial ...

Triple-negative breast cancer is one of the most aggressive cancers. The name tells the story: It lacks the three main ...